van Wering ER - Search Results

1

Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.

Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wünsche R, Rottier MM, Hählen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ. Zwaan CM, et al. Among authors: van wering er. Blood. 2000 Oct 15;96(8):2879-86. Blood. 2000. PMID: 11023525 Free article.

2

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, Stigter RL, van Wering ER, Janka-Schaub GE, Slater R, Pieters R. Stams WA, et al. Among authors: van wering er. Blood. 2003 Apr 1;101(7):2743-7. doi: 10.1182/blood-2002-08-2446. Epub 2002 Nov 14. Blood. 2003. PMID: 12433682 Free article.

3

Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER, Janka-Schaub GE, Evans WE, Pieters R. Stams WA, et al. Among authors: van wering er. Blood. 2005 Jun 1;105(11):4223-5. doi: 10.1182/blood-2004-10-3892. Epub 2005 Feb 17. Blood. 2005. PMID: 15718422 Free article.

4

Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R. Stams WA, et al. Among authors: van wering er. Clin Cancer Res. 2005 Apr 15;11(8):2974-80. doi: 10.1158/1078-0432.CCR-04-1829. Clin Cancer Res. 2005. PMID: 15837750

5

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.

Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JP. Balgobind BV, et al. Among authors: van den heuvel eibrink mm, van den ouweland am, van wering er, van vlierberghe p. Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2. Blood. 2008. PMID: 18172006 Free article.

6

CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.

van Grotel M, van den Heuvel-Eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, Pieters R, Meijerink JP. van Grotel M, et al. Among authors: van den heuvel eibrink mm, van noesel mm, van wering er. Pediatr Blood Cancer. 2008 Dec;51(6):737-40. doi: 10.1002/pbc.21707. Pediatr Blood Cancer. 2008. PMID: 18683236

7

Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis.

Zwaan CM, Reinhardt D, Corbacioglu S, van Wering ER, Bökkerink JP, Tissing WJ, Samuelsson U, Feingold J, Creutzig U, Kaspers GJ. Zwaan CM, et al. Among authors: van wering er. Blood. 2003 May 15;101(10):3868-71. doi: 10.1182/blood-2002-07-1947. Epub 2003 Jan 23. Blood. 2003. PMID: 12543868 Free article. Clinical Trial.

8

Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.

Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A, Henze G, Pieters R, Hählen K, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: van wering er. Eur J Cancer. 2005 Jun;41(9):1300-3. doi: 10.1016/j.ejca.2005.02.026. Eur J Cancer. 2005. PMID: 15869873

9

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.

Appel IM, Kazemier KM, Boos J, Lanvers C, Huijmans J, Veerman AJ, van Wering E, den Boer ML, Pieters R. Appel IM, et al. Leukemia. 2008 Sep;22(9):1665-79. doi: 10.1038/leu.2008.165. Epub 2008 Jun 26. Leukemia. 2008. PMID: 18580955 Clinical Trial.

10

Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.

Kaspers GJ, Veerman AJ, Van Wering ER, Van Der Linden-Schrever BE, Van Zantwijk CH, Van Der Does-Van Den Berg A, Pieters R. Kaspers GJ, et al. Among authors: van zantwijk ch, van der linden schrever be, van der does van den berg a, van wering er. Leukemia. 1996 Apr;10(4):675-81. Leukemia. 1996. PMID: 8618446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters